In a 72-year-old woman with chronic obstructive pulmonary disease and right atrial enlargement, should she be referred to cardiology?

Yes, cardiology referral is warranted for a 72-year-old woman with COPD and right atrial enlargement.

Right atrial enlargement in COPD patients signals increased risk for atrial arrhythmias and right heart dysfunction that requires cardiac evaluation, even when the enlargement may be secondary to pulmonary disease.

Rationale for Referral

Right Atrial Enlargement as a Risk Marker

Right atrial enlargement in COPD is not merely an incidental finding—it represents hemodynamic stress and predicts serious cardiac complications:

• Right atrial enlargement independently predicts atrial fibrillation development in COPD patients (OR 1.34,95% CI 1.16-1.56) 1
• P pulmonale (ECG marker of right atrial abnormality) is an independent predictor of arrhythmias in COPD (OR 3.2,95% CI 1.3-7.8) 2
• The cumulative incidence of atrial arrhythmias in pulmonary hypertension reaches 25% after 5 years, and these arrhythmias "compromise cardiac output and almost invariably lead to further clinical deterioration" 3

Why Cardiology Evaluation is Essential

The 2015 ESC/ERS Pulmonary Hypertension Guidelines 3 emphasize that right atrial enlargement on chest radiograph is a sign of more advanced pulmonary hypertension requiring comprehensive cardiac assessment. While ECG has limited sensitivity for detecting right ventricular hypertrophy in COPD 4, the presence of right atrial enlargement suggests:

1. Possible pulmonary hypertension requiring hemodynamic assessment
2. Right heart dysfunction needing echocardiographic evaluation beyond what primary care typically provides
3. Elevated arrhythmia risk requiring rhythm monitoring strategies

What Cardiology Should Evaluate

The cardiologist should assess:

• Echocardiography with specific attention to:

  • Right atrial area/volume quantification
  • Right ventricular function and size
  • Tricuspid regurgitation severity
  • Estimated pulmonary artery systolic pressure 3

• Arrhythmia risk stratification:

  • Consider Holter monitoring given the high prevalence of paroxysmal atrial fibrillation in this population 1, 2
  • ECG markers: P pulmonale, right axis deviation, right ventricular hypertrophy 2

• Pulmonary hypertension assessment:

  • Clinical signs of right heart failure
  • Need for right heart catheterization if pulmonary hypertension suspected 3

Clinical Pitfalls to Avoid

Do not dismiss right atrial enlargement as "just from COPD"—while COPD causes characteristic ECG changes (low voltage, rightward axis, persistent S waves in precordial leads) 4, right atrial enlargement specifically indicates hemodynamic consequences requiring cardiac expertise.

The combination of COPD and cardiac disease is particularly dangerous: Patients with both conditions face delayed CHF diagnosis, confounding symptoms, and altered cardiac mechanics from lung hyperinflation 5. Early cardiac involvement prevents these complications.

Atrial fibrillation in this population is especially problematic: When AF develops in COPD patients with right atrial enlargement, it causes rapid clinical deterioration 3 and has higher recurrence rates even after ablation 6.

Age and Severity Considerations

At 72 years old, this patient likely has:

• Higher Charlson Comorbidity Index (associated with AF risk in COPD) 1
• Greater likelihood of clinically severe COPD (which correlates with increased AF frequency regardless of FEV1) 7
• Potential for subclinical left ventricular dysfunction that conventional assessment might miss 5

The referral should be made promptly rather than waiting for symptom progression, as right atrial enlargement represents established hemodynamic stress requiring specialized cardiac evaluation and monitoring strategies.